Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Effect of Robotic Assisted Therapy on Hand Functions, Grip Strength and Proprioception in Children With Hemiplegia

NCT07249866 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-11
Last updated
2025-11-25

Condition(s) studied

Cerebral Palsy, Spastic

Investigational drug(s) / intervention(s)

Hand rehabilitation robotic glovesoccupational therapy

Hand rehabilitation robotic gloves: robotic gloves assist in hand functions

occupational therapy: designed traditional occupational therapy program

Study summary

Statement of the problem:

Does robotic assisted therapy have an effect on hand functions, grip strength and proprioception in children with hemiplegic cerebral palsy?

Significance of the study:

New technologies allow and promote active involvement, leading directly to functional changes that are far beyond those obtained with conventional therapy. Many features of robotic therapy may contribute to enhanced recovery of upper limb motor function. These include task-specific practice, intensity of repetition, robotic assistance, enhanced sensory feedback, continual motivation (because every trial yields a degree of success, even if robot assistance is required).

The implementation of robotics with hemiplegic cerebral palsy focuses on functional motor performance by providing intensive repetitive training, sensorimotor integration and cognitive engagement through goal-directed tasks to address the underlying symptoms. Robotic technologies offer numerous potential advantages over conventional therapies, chief among these being the ability to provide high-intensity repetitive training. Robotic treatment is a novel approach that has demonstrated promise in enhancing motor function, enhancing the quality of life, and lessening the burden on caregivers.

Eligibility

Sex
ALL
Min age
6 Years
Max age
9 Years
Healthy volunteers
No
Inclusion Criteria: * Their ages range from 6-9 years * They have mild to moderate spasticity (grade 1- 2) according to Modified Ashworth Scale * Their motor function will be at level I and II according to Gross Motor Function Classification System GMFCS * Their manual abilities will be at level II and Level III according to Manual Ability classification system * They will be able to understand and follow instructions Exclusion Criteria: * Fixed deformity in any joints of the upper limb. * Previous history of surgical intervention in the upper limb. * Auditory, visual and cognitive problems. * Botulinum Toxin injection in last 6 months.

Primary outcome measure(s)

  • hand grip strength by hand held dynamometer — 8 weeks
    the hand grip strength will be measured by hand held dynamometer
  • hand functions ( fine motor precision and integration measured by Bruininks-Oseretsky Test of Motor Proficiency — 8 weeks
    hand functions will be measured by Bruininks-Oseretsky Test of Motor Proficiency
  • wrist joint proprioception by digital goniometer — 8 weeks
    wrist joint position sense will be measured by digital goniometer

Trial sites (1)

FacilityCityRegionStatus
Cairo University Cairo State/Province
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07249866 on ClinicalTrials.gov ↗ ← All trials in Egypt